Bristol-Myers Squibb (BMY) - 12 Year Stock Split History

Historical stock splits for Bristol-Myers Squibb since 2006. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $94.553B $20.776B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $342.875B 16.39
Pfizer (PFE) United States $224.185B 13.80
Novartis AG (NVS) Switzerland $187.621B 16.09
Merck (MRK) United States $169.698B 15.17
AbbVie (ABBV) United States $149.801B 15.27
Novo Nordisk (NVO) Denmark $122.714B 20.33
Sanofi (SNY) France $105.515B 13.36
GlaxoSmithKline (GSK) United Kingdom $101.582B 13.89
Eli Lilly (LLY) United States $97.721B 19.40
AstraZeneca (AZN) United Kingdom $94.553B 9.90